Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
about
Can asthma control be improved by understanding the patient's perspective?The impact of generic-only drug benefits on patients' use of inhaled corticosteroids in a Medicare population with asthma.Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles.Fluticasone is associated with lower asthma-related costs than leukotriene modifiers in a real-world analysis.
P2860
Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inhaled fluticasone propionate ...... e in the management of asthma.
@ast
Inhaled fluticasone propionate ...... e in the management of asthma.
@en
Inhaled fluticasone propionate ...... e in the management of asthma.
@nl
type
label
Inhaled fluticasone propionate ...... e in the management of asthma.
@ast
Inhaled fluticasone propionate ...... e in the management of asthma.
@en
Inhaled fluticasone propionate ...... e in the management of asthma.
@nl
prefLabel
Inhaled fluticasone propionate ...... e in the management of asthma.
@ast
Inhaled fluticasone propionate ...... e in the management of asthma.
@en
Inhaled fluticasone propionate ...... e in the management of asthma.
@nl
P2093
P1433
P1476
Inhaled fluticasone propionate ...... e in the management of asthma.
@en
P2093
P2860
P304
P356
10.2165/00019053-200018050-00008
P577
2000-11-01T00:00:00Z
P6179
1046077118